Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service
Conclusions
The NMS significantly increased the proportion of patients adhering to their new medicine by about 10%, compared with normal practice.
Trial registration numbers
ClinicalTrials.gov trial reference number NCT01635361 (http://clinicaltrials.gov/ct2/show/NCT01635361). Current Controlled trials: trial reference number ISRCTN 23560818 (http://www.controlled-trials.com/ISRCTN23560818/; DOI 10.1186/ISRCTN23560818). UK Clinical Research Network (UKCRN) study 12494 (http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=12494).
Source: BMJ Quality and Safety - Category: Journals (General) Authors: Elliott, R. A., Boyd, M. J., Salema, N.-E., Davies, J., Barber, N., Mehta, R. L., Tanajewski, L., Waring, J., Latif, A., Gkountouras, G., Avery, A. J., Chuter, A., Craig, C. Tags: Original research Source Type: research
More News: Asthma | Chronic Obstructive Pulmonary | Diabetes | Diabetes Type 2 | Endocrinology | General Medicine | Health | Hypertension | Statistics | Study | UK Health